Clinical Trial Update: Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemotherapy plus anakinra for pancreatic adenocarcinoma is currently recruiting. Sponsored by Baylor Research Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: Baylor Research Institute | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: RECRUITING